Drug-induced thrombotic microangiopathy: An updated review of causative drugs, pathophysiology, and management

Drug-induced thrombotic microangiopathy (DITMA) represents 10%–13% of all thrombotic microangiopathy (TMA) cases and about 20%–30% of secondary TMAs, just behind pregnancy-related and infection-related forms. Although the list of drugs potentially involved as causative for TMA are rapidly increasing...

Descripción completa

Detalles Bibliográficos
Autores principales: Mazzierli, Tommaso, Allegretta, Federica, Maffini, Enrico, Allinovi, Marco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9868185/
https://www.ncbi.nlm.nih.gov/pubmed/36699080
http://dx.doi.org/10.3389/fphar.2022.1088031

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9868185/
https://www.ncbi.nlm.nih.gov/pubmed/36699080
http://dx.doi.org/10.3389/fphar.2022.1088031

Ejemplares similares